Atlas Trials

Eculizumab to Enable Renal Transplantation in Patients With History of Catastrophic Antiphospholipid Antibody Syndrome

Clinical trial NCT01029587 · COMPLETED

Trial details

NCT number
NCT01029587
Sponsor
Johns Hopkins University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Antiphospholipid Antibody SyndromeEnd Stage Renal Disease
Start date
2009-11-01
Primary completion
2010-05-06
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.